Abstract
The detected phenotypes in many diseases are caused from dysfunction in protein-protein, protein-DNA and receptor-ligand interactions. Therefore, determination of these molecular interactions followed by designing or screening the compounds to target these interactions provides a significant challenge in drug development. This review aims to highlight the yeast two-hybrid system in determination of protein-protein interactions and its possible outcomes in pharmaceutical research. The variations of the basic methodology as one- and three-hybrid systems are also disussed in relation to their potential pharmaceutical applications.
Similar content being viewed by others
REFERENCES
F. E. Regnier. Chromatography of complex protein mixtures. J. Chromatogr. 17:115–143 (1987).
E. M. Phizicky and S. Fields. Protein-protein interactions: Methods for detection and analysis. Microbiol. Rev. 59:94–123 (1995).
S. Fields and O.-K. Song. A novel genetic system to detect protein-protein interactions. Nature 340:245–246 (1989).
P. Colas and R. Brent. The impact of two-hybrid and related methods on biotechnology. Trends Biotechnol. 16:355–363 (1998).
K. H. Young. Yeast two-hybrid: So many interactions, (in) so little time. Biol. Reprod. 58:302–311 (1998).
M. Vidal and P. Legrain. Yeast forward and reverse “n”-hybrid systems. Nucleic Acids Res. 27:919–929 (1999).
C. Bai and S. J. Elledge. Gene identification using the yeast twohybrid system. Methods Enzymol. 273:331–347 (1996).
R. D. Gietz, B. Triggs-Raine, A. Robbins, K. C. Graham, and R. A. Woods. Identification of proteins that interact with a protein of interest: Applications of the yeast two-hybrid system. Mol. Cell. Biochem. 172:67–79 (1997).
T. Munder and A. Hinnen. Yeast cells as tools for target-oriented screening. Appl. Microbiol. Biotechnol. 52:311–320 (1999).
M. Johnston. The complete code for an eukaryotic cell. Genome sequencing. Curr. Biol. 6:500–503 (1996).
C. Guthrie and G. R. Fink. Guide to Yeast Genetics and Molecular Biology, Academic Press, San Diego, 1991.
S. Fields. The two-hybrid system to detect protein-protein interactions. Methods 5:116–124 (1993).
R. D. Gietz and R. A. Woods. High efficiency transformation of yeast with lithium acetate. In J. R. Johnstone (ed.), Molecular Genetics of Yeast: A Practical Approach, Oxford University Press, Oxford, 1994, pp. 121–134.
C. Bendixen, S. Gangloff, and R. V. Rothstein. A yeast mating selection scheme for highly efficient detection of protein-protein interaction. Nucleic Acids Res. 22:1778–1779 (1997).
L. Breeden and K. Nasmyth. Regulation of the yeast HO gene. Cold Spring Symposia on Quantitative Biology 50:643–650 (1985).
V. K. Jain and I. T. A. Magrath. A chemiluminescent assay for the quantification of β-galactosidase in LacZ-transfected cells. Anal. Biochem. 199:119–124 (1991).
T. Durfee, K. Becherer, P. L. Chen, S. H. Yeh, Y. Yang, A. E. Kilburn, W. H. Lee, and S. J. Elledge. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev. 7:555–569 (1993).
R. Brent and M. Ptashne. A eukaryotic transcriptional activator bearing the DNA specificity of prokaryotic repressor. Cell 43: 729–736 (1985).
E. A. Golemis and R. Brent. Fused protein domains inhibit DNA binding by lexA. Mol. Cell Biol. 12:3006–3007 (1992).
S. Dalton and R. Treisman. Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element. Cell 68:597–612 (1992).
T. Wang, P. K. Donahoe, and A.S. Zervos. Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12. Science 265:674–676 (1994).
P. L. Bartel, J. A. Roecklein, D. SenGrupta, and S. Fields. A protein linkage map of Escherichia coli bacteriophage T7. Nat. Genet. 12:72–77 (1996).
J. R. Hudson, E. P. Dawson, K. L. Rushing, C. H. Jackson, D. Lockshon, D. Conover, C. Lanciault, J. R. Harris, S. J. Simmons, R. Rothstein, and S. Fields. The complete set of predicted genes from Saccharomyces cerevisiae in a readily useable form. Genome Res. 7:1169–1173 (1997).
S. Brenner and R. A. Lerner. Encoded combinatorial chemistry. Proc. Natl. Acad. Sci. USA 89:5381–5383 (1992).
L. M. Kauvar. Peptide mimetic drugs: A comment on progress and prospects. Nat. Biotechnol. 14:296–298 (1996).
M. R. Pavia, M. P. Cohen, G. J. Dilley, G. R. Dubuc, T. L. Durgin, F. W. Forman, M. E. Hediger, G. Milot, T. S. Powers, I. Sucholeiki, S. Zhou, and D. G. Hangauer. The design and synthesis of substituted biphenyl libraries. Bioorg. Med. Chem. 4: 659–666 (1996).
B. Li and S. Fields. Identification of mutations in p53 that affect its binding to SV40 large T antigen by using the yeast two-hybrid system. FASEB J. 7:957–963 (1993).
M. Rose and D. Botstein. Structure and function of the yeast URA3 gene. Differentially regulated expression of hybrid betagalactosidase from overlapping coding sequences in yeast. J Mol Biol. 1704:883–904 (1983).
C. A. Leanna and M. Hannink. The reverse two-hybrid system: A genetic scheme for selection against specific protein/protein interactions. Nucleic Acids Res. 24:3341–3347 (1996).
H.-M. Shih, P. S. Goldman, A. J. DeMaggio, S.M. Hollenberg, R. H. Goodman, and M. F. Hoekstra. A positive genetic selection for disrupting protein-protein interactions: Identification of CREB mutations that prevent association with the coactivator CBP. Proc. Natl. Acad. Sci. USA 93:13896–13901 (1996).
M. Vidal, R. B. Brachmann, A. Fattaey, E. Harlow, and J. D. Boeke. Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions. Proc. Natl. Acad. Sci. USA 93:10315–10320 (1996).
M. Vidal, P. Braun, E. Chen, J. D. Boeke, and E. Harlow. Genetic characterisation of a mammalian protein-protein interaction domain by using a yeast reverse two-hybrid system. Proc. Natl. Acad. Sci. USA 93:10321–10326 (1996).
J. Huang and S. L. Schreibler. A yeast-genetic system for selecting small molecule inhibitors of protein-protein interactions in nanodroplets. Proc. Natl. Acad. Sci. USA 94:13396–13401 (1997).
N. F. Kaufer, H. M. Fried, W. F. Schwindinger, M. Jasin, and J. R. Warner. Cycloheximide resistance in yeast: the gene and its protein. Nucleic Acids Res. 11:3123–3135 (1983).
K. Young, S. Lin, L. Sun, E. Lee, M. Modi, S. Hellings, M. Husbands, B. Ozenberger, and R. Franco. Identification of a calcium channel modulator using a high throughput yeast two-hybrid screen. Nature Biotechnol. 16:946–950 (1998).
M. S. Salvato and K. S. Rai. Arenaviruses. In L. H. Collier and B. W. J. Mahy (eds.), Topley and Wilson's microbiology and microbial infections, Arnold Publishing, London, United Kingdom, 1997, pp. 629–650.
Z. Topcu, D. L. Mack, R. A. Hromas, and K. L. B. Borden. The promyelocytic leukemia protein interacts with the proline-rich homeodomain protein PRH: a RING may link hematopoiesis and growth control. Oncogene 18:7091–7100 (1999).
K. L. B. Borden, E. J. Campbell-Dwyer, and M. S. Salvato. An arenavirus RING (zinc-binding) protein binds the oncoprotein PML and relocates PML nuclear bodies to the cytoplasm. J. Virol. 72:758–766 (1998).
J. J. Li and I. Herskowitz. Isolation of ORC6, a component of the yeast origin recognition complex by a one-hybrid system. Science 262:1870–1874 (1993).
E. J. Licitra and J. O. Liu. A three hybrid system or detecting small ligand-protein receptor interactions. Proc. Natl. Acad. Sci. USA 93:12817–12821 (1996).
J. Zhang and S. Lautar. A yeast three-hybrid method to clone ternary protein complex components. Anal. Biochem. 242:68–72 (1996).
G. C. Kneale. DNA-Protein interactions: Principles and Protocols, Humana Press, Totowa, New Jersey, 1994.
B. Rudakoff, K. Undisz, G. Mayer, L. Sobek, G. Kaufmann, R. Thiericke, S. Grabley, and T. Munder. Dual reporter systems in yeast and mammalian cells for assessing progesterone receptor modulators. J. Cell. Biochem. 73:126–136 (1999).
J. L. Nitiss. Investigating the biological functions of DNA topoisomerases in eukaryotic cells. Biochim. Biophys. Acta 1400:63–81 (1998).
Z. Topcu and F. J. Castora. Mammalian mitochondrial DNA topoisomerase I preferentially relaxes supercoils in plasmids containing specific mitochondrial DNA sequences. Biochim. Biophys. Acta 1264:377–387 (1995).
G. Capranico and M. Binaschi. DNA sequence selectivity of topoisomerases and topoisomerase poisons. Biochim. Biophys. Acta 1400:185–194 (1998).
F. Tirode, C. Malaguti, F. Romero, R. Attar, J. Camonis, and J. M. Egly. A conditionally expressed third partner stabilizes or prevents the formation of a transcriptional activator in a threehybrid system. J. Biol. Chem. 272:22995–22999 (1997).
H. A.Vasavada, S. Ganguly, F. J. Germino, Z. X. Wang, and S. M. Weissman. A contingent replication assay for the detection of protein-protein interactions in animal cells. Proc. Natl. Acad. Sci. USA 88:10686–10690 (1991).
G. Boguslawski. Effect of polymixin B sulfate and polymixin B nonapeptide on growth and permeability on the yeast Saccharomyces cerevisiae. Mol. Gen. Genet. 199:401–405 (1985).
M. Brendel. A simple method for the isolation and characterization of thymidilate uptaking mutants in Saccharomyces cerevisiae. Mol. Gen. Genet. 147:209–215 (1976).
R. F. Gaber, D. M. Copple, B. Kenedy, M. Vidal, and M. Bard. The yeast gene ERG6 is required for normal membrane function but is not essential for biosynthesis of the cell-cycle-sparking sterol. Mol. Cell Biol. 9:3447–3456 (1989).
E. Balzi and A. Goffeau. Yeast multidrug resistance: The PDR network. J. Bioenerg. Biomembr. 27:71–76 (1995).
A. Kralli, S. P. Bohen, and K. T. Yamamoto. LEM1, an ATPbinding cassette transporter, selectively modulates the biological potency of steroid hormones. Proc. Natl. Acad. Sci. USA 92:4701–4705 (1995).
J. R. Broach and J. Thorner. High-throughput screening for drug discovery. Nature 384:14–16 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Topcu, Z., Borden, K.L.B. The Yeast Two-hybrid System and Its Pharmaceutical Significance. Pharm Res 17, 1049–1055 (2000). https://doi.org/10.1023/A:1026493310144
Issue Date:
DOI: https://doi.org/10.1023/A:1026493310144